Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06292091Phase 1Completed
Phase 1, open-label trial of captopril in hypertension (HTN) (3 arms), sponsored by Seoul National University Hospital. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started Feb 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06292091.